Literature DB >> 17713016

Serum levels of soluble HLA and IL-2R molecules in patients with urogenital chlamydia infection.

Victor V Novikov1, Natalya I Egorova, Georgii Yu Kurnikov, Irina V Evsegneeva, Anatoly Yu Baryshnikov, Alexandr V Karaulov.   

Abstract

Cellular immunity plays a central role in immune response to chlamydial infection, and soluble forms of immune cell membrane antigens take part in the regulation of immune response. Using an immunoenzymatic method, we determined serum levels of soluble HLA molecules (sHLA-I and sHLA-DR) and soluble CD25 molecules (sCD25) in patients with genital chlamydial infection. Specimens from patients with nonspecific inflammation of the urogenital tract were studied and healthy volunteers served as controls. We revealed that serum levels of sHLA-DR and sCD25 increased 3.5- and 2.3-fold, respectively, during chlamydial infection, while the levels of sHLA-I were not changed. Nonspecific inflammation of the urogenital tract was characterized by a 1.5-fold increase in sHLA-I, a 1.6-fold decrease in sCD25, and no changes of sHLA-DR levels in comparison with healthy volunteers. We concluded that Th1 immune responses might dominate during genital chlamydial infection contrary to the state of nonspecific inflammation of urogenital tract.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713016     DOI: 10.1007/978-0-387-72005-0_30

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Relationship of the Content of Systemic and Endobronchial Soluble Molecules of CD25, CD38, CD8, and HLA-I-CD8 and Lung Function Parameters in COPD Patients.

Authors:  Nailya Kubysheva; Larisa Postnikova; Svetlana Soodaeva; Viкtor Novikov; Tatyana Eliseeva; Ildar Batyrshin; Timur Li; Igor Klimanov; Alexander Chuchalin
Journal:  Dis Markers       Date:  2017-08-07       Impact factor: 3.434

2.  Plasma concentrations of soluble IL-2 receptor α (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients.

Authors:  Kate Downes; M Loredana Marcovecchio; Pamela Clarke; Jason D Cooper; Ricardo C Ferreira; Joanna M M Howson; Jennifer Jolley; Sarah Nutland; Helen E Stevens; Neil M Walker; Chris Wallace; David B Dunger; John A Todd
Journal:  Diabetologia       Date:  2013-11-22       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.